In this issue:
Ofatumumab vs teriflunomide in MS
Effect of ocrelizumab on vaccine responses in MS patients
Use of natural medicine and dietary supplements with conventional MS medicine
Mitigating alemtuzumab-associated autoimmunity in MS
Tailoring B cell depletion therapy in MS according to memory B cell monitoring
Long-term effect of natalizumab in RRMS
Onset of progressive motor impairment in patients with critical CNS demyelinating lesions
Disability outcomes of early cerebellar and brainstem symptoms in MS
10-year risk estimate of a clinical event with RIS
Backward walking sensitively detects fallers in persons with MS
Please login below to download this issue (PDF)